Cargando…
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
Sjögren’s syndrome (SS) is a chronic inflammatory autoimmune disease characterized by diminished secretory function of the exocrine glands. Treatments for hyposalivation are limited to the use of saliva substitutes and medications that provide only temporary relief. In light of the high degree of ne...
Autores principales: | Wang, Ching-Shuen, Maruyama, Christina L., Easley, Justin T., Trump, Bryan G., Baker, Olga J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374540/ https://www.ncbi.nlm.nih.gov/pubmed/28361884 http://dx.doi.org/10.1038/srep45525 |
Ejemplares similares
-
Author Correction: AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
por: Wang, Ching-Shuen, et al.
Publicado: (2018) -
Genome-wide end-sequenced BAC resources for the NOD/MrkTac(☆) and NOD/ShiLtJ(☆☆) mouse genomes
por: Steward, Charles A., et al.
Publicado: (2010) -
Metabolic abnormalities exacerbate Sjögren’s syndrome by and is associated with increased the population of interleukin–17–producing cells in NOD/ShiLtJ mice
por: Hwang, Sun-Hee, et al.
Publicado: (2020) -
Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren's-Like NOD/ShiLtJ Mice
por: Hu, Peng, et al.
Publicado: (2021) -
AT‐RvD1 combined with DEX is highly effective in treating TNF‐α‐mediated disruption of the salivary gland epithelium
por: Easley, Justin T., et al.
Publicado: (2016)